1
Investors
About
Alp Bio develops a platform that combines human tonsil organoid ex vivo assays and protein AI to predict, validate, and reduce immunogenicity risk in therapeutic antibodies prior to clinical development.
Explore Alp Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.